Back to News
Market Impact: 0.2
Bet on This New GLP-1 ETF to Gain Exposure to a Booming Market
Source: zacks.com
Healthcare & BiotechProduct Launches
REX Shares launched the REX Peptide ETF (PEPT), offering global exposure to the peptide industry across drug developers, manufacturers and delivery platforms. The brief announcement provides no fund size, performance data or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- Sovereign wealth funds' China and Hong Kong investments surge 190% after a bruising slump
- Apple's iPhone Duo in short supply — plus, the 2 stocks fueling an AI rebound
- Arcus Biosciences prices $250 million stock offering at $17.50
- AstraZeneca says U.S. FDA approves rare kidney disease drug
- Tesla stars Optimus robot production in California as profit falls 43%
- Mark Zuckerberg says Meta is 'entering a new phase' with Muse